• Depot
  • Watchlist
  • Glocke
  • Handeln

    • Hikma Pharmaceuticals News

    22,60 € +3,67% +0,80 €
    26.04.24 16:09:19 Tradegate aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A0HG69
    ISIN: GB00B0LCW083
    US-Symbol: HKMPF
    Typ: Aktie

    Hikma Pharmaceuticals News

    03.10.23 - PR Newswire
    Hikma marks two-year anniversary of KLOXXADO® launch by surpassing 375,000 doses donated in the US
    Hikma marks two-year anniversary of KLOXXADO® launch by surpassing 375,000 doses donated in the US PR Newswire
    18.09.23 - dpa-AFX
    INDEX-MONITOR: Marks & Spencer und drei weitere Unternehmen nun im 'Footsie'
    Im wichtigsten britischen Aktienindex werden an diesem Montag folgende vier Unternehmen aufgenommen: Der Bekleidungshersteller Marks & Spencer steigt in den FTSE 100 ...
    29.12.22 - wallstreet:online Zentralredaktion
    "Finanzwort des Jahres 2023": Disinflation: Diese Aktien könnten vom kommenden Megatrend profitieren
    Nach einem Jahr mit zweistelligen Inflationsraten in vielen Ländern prognostiziert die UBS nun eine "starke" Disinflation für 2023. Welche Aktien dabei eine Rolle spielen könnten!
    20.05.22 - The Motley Fool
    Aktien: 1 Qualitätswert zum Ausverkaufspreis!
    Aktuell korrigieren vor allem in den USA die Aktien- Kurse überproportional stark. Der Nasdaq-100-Index ist beispielsweise über 28 % gefallen (19.05.2022). Doch diese ...
    29.04.22 - PR Newswire
    Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals
    Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals PR Newswire
    29.04.22 - PR Newswire
    Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals
    Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals PR Newswire
    29.03.22 - PR Newswire
    Hikma Ventures invests in Tact.ai, an AI-powered customer engagement platform for life sciences companies
    Hikma Ventures invests in Tact.ai, an AI-​powered customer engagement platform for life sciences companies PR Newswire
    09.06.21 - PR Newswire
    Hikma appoints Patrick Genestin to lead Generics Business Development
    Hikma appoints Patrick Genestin to lead Generics Business Development PR Newswire
    30.04.21 - PR Newswire
    Hikma announces US FDA approval of KLOXXADOTM (naloxone hydrochloride) nasal spray 8mg
    Hikma announces US FDA approval of KLOXXADOTM (naloxone hydrochloride) nasal spray 8mg Important new option for reversing opioid overdoses PR Newswire
    28.04.21 - PR Newswire
    Hikma announces exclusive agreement with AFT Pharmaceuticals for injectable non-opioid pain medication Combogesic® IV in the US
    Hikma announces exclusive agreement with AFT Pharmaceuticals for injectable non-​opioid pain medication Combogesic® IV in the US PR Newswire
    20.04.21 - PR Newswire
    Hikma resumes launch of generic Advair Diskus®
    Hikma resumes launch of generic Advair Diskus® PR Newswire
    18.03.21 - PR Newswire
    Hikma Pledges additional $40,000 to local US food banks and pantries in fight against hunger
    Hikma Pledges additional $40,000 to local US food banks and pantries in fight against hunger Company's employee matching donation campaign has provided over 600,000 ...
    18.02.21 - PR Newswire
    Hikma Donates Over $4 Million USD in Medicines and Signs New Long-term Partnerships with Dispensary of Hope, Direct Relief, Americares, Brother's Brother Foundation and the National Children's Cancer Society
    Hikma Donates Over $4 Million USD in Medicines and Signs New Long-term Partnerships with Dispensary of Hope, Direct Relief, Americares, Brother's Brother Foundation and the ...
    18.02.21 - PR Newswire
    Hikma Donates Over $4 Million USD in Medicines and Signs New Long-term Partnerships with Dispensary of Hope, Direct Relief, Americares, Brother's Brother Foundation and the National Children's Cancer Society
    Hikma Donates Over $4 Million USD in Medicines and Signs New Long-term Partnerships with Dispensary of Hope, Direct Relief, Americares, Brother's Brother Foundation and the ...
    13.01.21 - PR Newswire
    Hikma's commitment to environmental performance recognised with "A-" rating in 2020 CDP Global Climate Change Report
    Hikma's commitment to environmental performance recognised with "A-" rating in 2020 CDP Global Climate Change Report Improved rating elevates Hikma to global leadership ...
    17.12.20 - PR Newswire
    Hikma launches generic Advair Diskus® following FDA approval
    Hikma launches generic Advair Diskus® following FDA approval PR Newswire
    20.10.20 - PR Newswire
    Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-to-administer medicine
    Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-​to-administer medicine Adds ready-​to-administer injectable product to companies' ...
    20.10.20 - PR Newswire
    Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-to-administer medicine
    Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-​to-administer medicine PR Newswire
    03.09.20 - PR Newswire
    Hikma receives favourable court ruling for its generic Vascepa®
    Hikma receives favourable court ruling for its generic Vascepa® PR Newswire
    26.08.20 - PR Newswire
    Hikma Ventures Participates in CAD4.0 million Series A Financing Round for SeamlessMD to Expand Digital Patient Engagement Leadership
    Hikma Ventures Participates in CAD4.0 million Series A Financing Round for SeamlessMD to Expand Digital Patient Engagement Leadership PR Newswire

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »